Retina ASRS 2021

AGENDA | OCTOBER 7

7:30 - 8:35 AM

Check-in & Networking Breakfast

8:30 - 8:40 AM

Opening & Hot Topics in the Retina Space

Presented By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

8:40 - 8:55 AM

Retina Pharmaceuticals Market Update

Presented By:
Peter Downs, Author & Analyst - Market Scope

8:55 - 10:15 AM

Innovation Showcase

8:55 - 9:02 AM | Outlook Therapeutics | C. Russell Trenary III - President & CEO
9:02- 9:09 AM | Iveric Bio | Pravin Dugel, MD - President
9:09 - 9:16 AM | GenSight Biologics | Magali Taiel, MD - Chief Medical Officer
9:16 - 9:23 AM | Ocuphire Pharma | Mina Sooch - CEO & Co-Founder
9:23 - 9:30 AM | Samsara Vision | Thomas Ruggia, President & CEO
9:30 - 9:37 AM | LumiThera | Clark E. Tedford, PhD - Co-Founder, President & CEO
9:37 - 9:44 AM | Pixium Vision | Lloyd Diamond - President & CEO
9:44 - 9:51 AM | Oxular | Friedrich Asmus, MD - Chief Medical Officer
9:51 - 9:58 AM | Annexon Biosciences | Douglas Love - President & CEO
9:58 - 10:05AM | Gemini Therapeutics | Samuel Barone, MD, - Chief Medical Officer

10:15 - 10:50 AM

Morning Networking & Refreshment Break

10:50 - 11:50 AM

Spotlight on Cell & Gene Therapy

Company Showcase
11:00 - 11:07 AM | DTx Pharma | Arthur Suckow, PhD - Co-Founder & CEO
11:07 - 11:14 AM| REGENXBIO | Stephen Pakola, MD - Chief Medical Officer
11:14 - 11:21 AM | Eyevensys | Patricia Zilliox, PhD - President & CEO
11:21 - 11:28 AM | Nanoscope Therapeutics | Samarendra Mohanty, PhD - Co-Founder, President & Chief Scientific Officer
11:28 - 11:35 AM | Regenerative Patch Technologies | Suber Huang, MD, MBA, FASRS

Clinical Panel Discussion

Panelists:

Suber Huang, MD, MBA, FASRS, CEO - Retina Center of Ohio/Future Vision Foundation
Aaron Osborne, MD - Ophthalmology Drug Developer & Consultant
Jose Sahel, MD, Chairman - University of Pittsburgh Medical Center
Charles Wykoff, MD - Retina Consultants of Texas

Moderated By:
Mark Humayun, MD, PhD, Professor of Ophthalmology and Director
University of Southern California Roski Eye Institute

11:50 AM - 12:50 PM

Spotlight on Drug Delivery

Company Showcase
12:00 - 12:07 PM | Re-Vana Therapeutics | Michael O'Rourke - CEO
12:07 - 12:14 PM | Aerie Pharmaceuticals | Casey C. Kopczynski, PhD - Chief Scientific Officer
12:14 - 12:21 PM | Clearside Biomedical | Thomas Ciulla, MD - Chief Medical Officer Officer
12:21 - 12:28 PM | EyePoint Pharmaceuticals | Nancy Lurker - President & CEO

Clinical Panel Discussion

Panelists:
Robert L Avery, MD, Founder & CEO - California Retina Consultants
Sharon Bakalash, MD, PhD, CBA, Founder & CEO - SB Strategic Development Consultants
Maria Berrocal, MD, Berrocal & Associates

Moderated By:
Sophie Bakri, MD, Professor and Chair of Ophthalmology - Mayo Clinic

12:50 - 1:50 PM

Networking Lunch & Innovator Award

1:30 - 1:50 PM | Innovator Award
Recipient:
Stanley Chang, MD, Chairman of the Department of Ophthalmology - Columbia University Medical Center (confirmed)

Interviewed By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

1:50 - 2:45 PM

Spotlight on AI, Diagnostics and Therapeutics

Company Showcase
1:55 - 2:02 PM | Notal Vision | Kester Nahen, PhD, - CEO
2:02 - 2:09 PM | Eyenuk | Kaushal Solanki, PhD, UCSB - Founder & CEO
2:02 - 2:09 PM | Deepmind | Namma Hammel

Panel Discussion

Rishi Singh, MD, Staff Physician and Professor of Ophthalmology - Cleveland Clinic
Daniela Ferrara, MD, MSc, PhD, Senior Medical Director, Global Development Lead in Retinal Diseases, Ophthalmology Personalized Healthcare Program & Product Development - Genentech a member of the Roche Group

Moderated By:
Jay Duker, MD, Chairman of Ophthalmology - Tufts University School of Medicine/Chief Strategic Scientific Officer - EyePoint Pharmaceuticals

2:45 - 3:25 PM

Retina Pipeline Presentations

3:25 - 4:05 PM

Afternoon Networking & Refreshment Break

4:05 - 4:40 PM

Finding and Funding Assets in Retina

Participants:
Fred Guerard, CEO - Graybug Vision
Jason Menzo, COO - Foundation Fighting Blindness
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Senior Managing Director - Blackstone Life Sciences

4:40 - 5:15 PM

Retina Industry Panel

Participants:

Jeff Evanson, Chief Commercial Officer – Outlook Therapeutics
Paul Hallen, VP & Global Head, Retina & Glaucoma – Alcon
Robert Kissling, MD, VP, Medical & Clinical Affairs - Bausch + Lomb
Ram Palanki, PharmD, SVP, Commercial Strategy and Operations - REGENXBIO

Moderated By:
Firas M. Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

5:15 - 6:15 PM

Networking Reception